What are the recommendations for patients with NSTE-ACS and high-risk features who are not adequately pretreated with clopidogrel or ticagrelor?
In patients with NSTE-ACS and high-risk features (eg, elevated troponin) not adequately pretreated with clopidogrel or ticagrelor, it is useful to administer a GP IIb/IIIa inhibitor (abciximab, double-bolus eptifibatide, or high-dose bolus tirofiban) at the time of PCI.26,293,302,331,372 375 (Level of Evidence:A)